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Observations on immune reactions of human subjects to Types I, 
II and III pneumococci and their products have recently been re- 
ported  from  this  laboratory  (1).  These  observations  confirm the 
previous demonstrations of the general presence among normal adults 
of bactericidal power for  mouse-virulent type-specific pneumococci 
of  1  or  more of these 3  types,  the occasional presence of mouse- 
protective antibodies and the rare occurrence of type-specific aggluti- 
nins.  They extended previous conceptions of natural immunity by 
showing that the type-specific actions of the whole blood and serum 
occur with differing frequencies, and in  combinations that indicate 
their independence of one another.  A marked variation in the inci- 
dence of the type-specific actions of whole blood and serum was noted 
with the age of the subjects tested. 
The possibility of definitely identifying all but a  small percentage 
of strains of pneumococci with the aid of sera recently developed by 
Cooper and her coworkers (2) has made feasible more detailed studies 
of the occurrence of the various strains in health and disease.  Re- 
ports on the incidence of these newly classified types in the pneumonias 
of children (3) and in normal human subjects (4, 5) have already ap- 
peared and other studies of their occurrence in disease are in progress 
in this and other clinics.  A more intelligent approach is, therefore, 
* This study was aided, in part, by a grant in honor of Francis Weld Peabody 
from the Ella Sachs Plotz Foundation and, in part, from the William W. Welling- 
ton Fund of the Harvard Medical School. 
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offered  to  the  study  of immunity  to  pneumococci other  than  those 
included in Types I, II and III. 
It,  therefore,  seemed  of  interest  to  extend  the  above  mentioned 
observations  on  natural  immunity  to  include  certain  of  these  new 
types.  The  present  communication  is  concerned,  primarily,  with 
immune reactions of the blood and serum of a group of human subjects, 
free from recent pneumococcic infections.  Particular  attention  was 
given to those types, which have previously been described as immu- 
nologically related to, but not identical with,  typical strains of Types 
II and  III pneumococci  (6,  7). 
Materials and Methods 
The Types I, II and III strains of pneumococci employed throughout the in- 
vestigation were originally  obtained from the Antitoxin and Vaccine Laboratory 
of the Massachusetts Department of Public Health and have been used as stock 
strains in this laboratory for the past 3 years.  The following strains were ob- 
tained from Miss Georgia M. Cooper: Type V, Am., isolated in Feb., 1928, from 
the blood of a fatal case of lobar pneumonia; Type VI a, Fi., isolated in Feb., 1929, 
from a swab culture of a normal throat; Type VI b, Ro., isolated in Apr., 1931, 
from the sputum of a child suffering  from an acute upper respiratory infection; 
Type VIII, tie., isolated in Jan., 1928, from a mild case of lobar pneumonia; and 
Type IX, Bu.,  isolated in June,  1931, from the sputum of a  case of influenza. 
These strains are hereafter referred to by their type designation only.  1 
The virulence of all of these strains was maintained by daily passage through 
mice and transfer of mouse heart's blood into rabbit's blood broth, in which they 
were transplanted at 8 hour intervals.  In carrying out the experiments 10 to 16 
hour rabbits' blood broth cultures were used.  These cultures were found to con- 
tain 11 to 135 (rarely more) diplococci in 0.0000001 cc., as shown by the plate dilu- 
tion method.  With the exception of Type IX, they were regularly fatal for mice 
in one-tenth this amount and in most instances the organisms were of maximal 
virulence, so that doses  containing  1 or more organisms proved fatal within 48 
hours.  For simplicity the greatest dilution (in multiples of 10) containing 30 or 
more colonies on plating was considered to contain 100 diplococci or 10 lethal doses. 
The Type V and VIII organisms were agglutinated  to a  moderate degree in 
Type II and III antisera, respectively, but they were agglutinated in the homolo- 
gous typing serum to a  definitely  higher  titer.  The agglutination  reactions of 
these strains were as follows: 
1 We are very grateful to Miss Cooper and to Dr. William H. Park of the New 
York City Department of Health for supplying these strains and the various typ- 
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Type of serum  Type of antigen  Agglutinin  fiter  Type of antigen  Agglutinin  titer 
II  II  1:80  V  1:80 
V  II  0  V  1:160 
III  III  1:160  VIII  1:40 
VIII  III  1:10  VIII  1:160 
The VIa and VI b strains gave identical agglutination reactions in all typing 
sera.  No other significant cross-agglutinations were observed.  All of the strains 
grew consistently in smooth colonies on the surface of rabbits' blood agar plates. 
With the exception of the Type IX strain, all the organisms retained their specific 
agglutinating  characteristics,  as  well  as  their  virulence  for  mice,  throughout 
the time of this investigation.  The Type IX strain regularly failed to agglutinate 
in  the homologous antiserum  or  in  any of  the  other  typing sera  available,  it 
was  only partly  soluble  in bile,  grew in  small  smooth  colonies,  produced only 
a  very small area of methemoglobin in rabbits' blood agar plates after 48 hours 
incubation and usually failed to change the color of defibrinated human blood after 
24 hours' incubation, even when proliferation  was  demonstrable  by  transplants 
on the surface of blood agar plates.  This strain was irregular in its virulence for 
mice, the lethal dose being 0.0000001 cc. or more on most tests? 
The pneumococcidal action was studied in the whole defibrinated blood by the 
method of Todd, as employed by Ward (8).  Passive protection was tested by the 
simultaneous  intraperitoneal  injection  of progressive  dilutions  of  culture  with 
0.2 cc. amounts of serum, duplicate mice being used in most instances and for all 
culture controls.  Pneumococcidal power was said to be present when 100 or more 
organisms were killed in 0.5 cc. of blood and protection was considered significant 
when duplicate mice were each protected against 100 or more lethal doses.  Agglu- 
tinating antigens were prepared by resuspending the organisms from 8 hour plain 
broth cultures in a volume of normal saline equal to that of the original culture 
and adding 0.4 per cent formaldehyde.  Agglutination tests were carried out by 
incubating 0.2 cc. amounts of antigen and serum dilution together for 2 hours at 
37°C. and reading after overnight ice box storage. 
The subjects  for these  tests  were similar  to those employed in the  previous 
study  (1),  except  that  none of  the  infants  or children  were convalescent from 
infectious disease. 
Results of Pneumococcidal  Tests 
The  pneumococcidal  power  of  the  whole  defibrinated  blood  was 
tested against Types I, II, III, V, VI a, VI b, VIII and IX organisms 
in 72 normal subjects and hospital patients having no recent infection 
or history of pneumonia.  There  were  6  infants  from  2  weeks  to  7 
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months of age,  10 children from 1 to 9 years, 33 individuals from 16 
to 38 years,  15 from 40 to 58 years, and 8 over 64 years of age.  In 
several individuals,  tests with Type II or III or VIa  were omitted. 
TABLE  I 
Incidence  of Pneumococcidal  Action  against  Different  Types  and  among  Different 
Age Groups 
Type I 
Type II 
Type III 
Type V 
Type VI b 
Type VIII 
Type IX 
Subjects tested  ............. 
No. pneumococcidal  ........ 
Pneumococcidal, pet cent ..... 
Subjects tested  ............. 
No. pneumococcidal ........ 
Pneumococcidal, per cent ..... 
Subjects tested  ............. 
No. pneumococcidal  ........ 
Pneumococcidal, per cent ..... 
Subjects tested  ............. 
No. pneumococcidal  ........ 
Pneumococcidal, per cent ..... 
Subjects tested  ............. 
No pneumococcidal  ......... 
Pneumococcidal, per cent ..... 
Subjects tested  ............. 
No. pneumococcidal  ......... 
Pneumococcidal, per cent ..... 
Subjects tested  ............. 
No. pneumococcidal  ........ 
Pneumococcidal, per cent ..... 
2 wks. 
-  lyr. 
6 
0 
0 
6 
0 
0 
6 
0 
0 
6 
0 
0 
6 
3 
50.0 
6 
3 
50.0 
6 
6 
100.0 
Age group 
1-9  [ 16-38 [ 40-60  Over 
yrs.  yrs.  yrs.  64 yrs. 
10  I  33  15 
[ 
0  16  4 
0  48.5  26.7 
10  31  12 
9  28  11 
90.0  90.3  91.7 
10  25  9 
6  14  4 
60.0  56.0  44.4 
10  33  15 
8  27  10 
80.0  81.2  66.7 
9  33  15 
8  33  15 
88.91  100.0  100.0 
190  33  15 
31  15 
91"03393"9100.015 
32  15  [ 
Loo.ol  97.0  100.01 
Over  I  All 
ages 
8  72 
1  21 
12.5  29.2 
8  67 
7  54 
87.5  80.6 
8  58 
4  28 
50.0  48.4 
8  72 
3  48 
37.5  66.7 
8  71 
8  67 
100.0  94.4 
8  72 
8  66 
100.0  93.1 
8  71 
8  70 
100.0  98.6 
The frequency with which killing power was demonstrated in each 
age group and against each organism is shown in Table I  and repre- 
sented  graphically  in  Fig.  1.  The  curves  for  Types  I,  II  and  III 
pneumococci are  similar  to  those constructed  for  the  group  of sub- ~EAX~rELL ~'INLAND AND W.  D.  SUTLIFF 
jects included in the earlier study with these strains  (1).  It may be 
pointed  out  again  that  the  relative  incidence  of  pneumococcidal 
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FIG. 1. Percentage of persons in different age groups whose blood is bactericidal 
for various types of pneumococci.  The Roman numbers represent the types of 
pneumococci. 
power for each of these 3 types is the same in  every age group; that 
killing  is least  frequent  for Type I,  most frequent  for Type II and 100  IMMUNITY  REACTIONS  TO  PNEUMOCOCCI 
intermediate  in  frequency for Type III,  and  that  killing  power  for 
these 3  types is absent during the 1st year of life, is highest in early 
adult  life  and  becomes less  frequent  in  old  age.  The  anomalous 
position of the last point on the Type III curve in  Fig.  1 probably 
depends upon the small number of observations in this age group. 
The same relative incidence of pneumococcidal action in the blood 
of  individuals  of  different  ages  is  here  demonstrated  for  Type  V, 
which is seen to occupy a position intermediate between Type II and 
Type  III.  The  remaining  strains  were  all  killed  with  greater  fre- 
quency in the blood of individuals of all age groups.  The Type IX 
strain was killed in practically every specimen of blood tested.  The 
Types VI b and VIII strains occupied comparable positions between 
Types II and IX.  Since the results of tests with the VIa  and VI b 
strains  in  the individual  bloods were the same,  within  the limits  of 
error of the test, only the curve for Type VI b is included.  The order 
of relative frequency with which different types of pneumococci were 
killed by this group of individuals is, therefore, from least to greatest 
frequency, as follows:  I, III, V, II, VIII, VI and IX? 
For the purpose of evaluating the quantitative relationships of the 
killing power for the  various strains,  the number and percentage of 
persons who kill, respectively, 0  or 10,  100 to  10,000 and  100,000 or 
more pneumococci of each type are shown in Table II.  In the column 
3 It is possible, in the case of the Type IX pneumococcus, that we were dealing 
originally  with  a  variant 'that  maintained  its  characteristics  throughout  our 
experiments.  Since this paper was submitted, Miss Cooper was kind enough to 
send us a fresh transplant of the IX, Bu., strain.  Subcultures of this strain were 
bile-soluble,  agglutinated  specifically  in  Type IX  antiserum  and  had  cultural 
characteristics,  in whole human blood and on artificial media, similar to the other 
pneumococci.  The whole defibrillated blood of 12 hospital subjects over 58 years 
of age was tested with this strain, with the stock Types I, II and III and with a 
fresh transplant of the V, Am., strains.  The number of subjects killing, respec- 
tively, 0 or 10,  100 or 1000 and  10,000 or more pneumococci were as follows: 
Type 1--11, 1 and 0; Type II--4, 5 and 3; Type III--9, 3 and 0; Type V--6, 1 
and 5; and Type IX--3, 2 and 7.  Except for Type IX the results appear very 
similar to those described above.  Furthermore, the results of the Type III tests, 
when added to the above, tend to smooth out the latter part of the curve for that 
type.  For the Type IX the killing was not quite as universal as those recorded 
above.  It was,  however,  killed  with greater frequency and in larger numbers 
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representing  absence  of  killing  power  (0-10  diplococci),  the  types 
arrange  themselves in the reverse  order  to that noted above for  the 
presence of pneumococcidal action.  It is also seen that the percent- 
ages of persons killing 100,000  or more pneumococci of the different 
types align themselves by types in the same order  as in the  case of 
the frequency of killing.  This is shown graphically in Fig. 2. 
The immunological relationships of the Types  II  and  V  and  the 
Types  III  and  VIII  strains  in  artificially  prepared  immune  sera, 
indicated in part by  the cross-agglutination  reactions shown above, 
suggest that  similar relationships might be expected in the reactions 
of human blood with  these strains.  The  bactericidal  action  of in- 
TABLE  II 
Frequency  with  Which  Different  Numbers  of  Pneumococci  Are  Killed 
T~q~e 
I 
II 
III 
V 
VIb 
VIII 
IX 
No. of 
subjects 
tested 
72 
67 
58 
72 
71 
72 
71 
No. killing 
0-t0 
diplococel 
51 
12 
30 
24 
4 
6 
1 
Per cent 
of subjects 
70.8 
17.9 
51.7 
33.3 
5.6 
8.3 
1,4 
No. killing 
100-10,000 
dlplococcl 
19 
39 
26 
42 
26 
46 
20 
~er cen 
of subjec 
26.4 
58,2 
44.8 
58.3 
36.6 
63..9 
28.2 
No. killing 
100,000 
or more 
dlplococcl 
2 
16 
2 
6 
4I 
20 
50 
Per cent 
of subjects 
2.8 
23.9 
3.4 
8,3 
57,7 
27.7 
70.4 
dividual blood samples on the various strains failed to indicate such 
correlations.  The action of any blood  against  Type V  or against 
Type VIII pneumococci was  apparently independent of the action 
of that blood on the Type II or the Type III organisms, respectively. 
On the other hand, calculations of the frequency with which bac- 
tericidal power for each combination of 2 types was present for both, 
or absent for both, in  the same blood samples showed a  small, but 
constant,  tendency favoring the  simultaneous presence, as  well  as 
absence, of pneumococcidal action against each pair of type-specific 
strains.  For every combination of 2 types, bactericidal action was 
present for both, or absent for both, in the same blood in from 3 to 13 
per cent more subjects than  was expected from calculations based 
upon the frequency  with which each type separately was killed.  Thus 102  IMMUNITY  ]REACTIONS  TO  PNEU•OCOCCI 
there appears a  slight, but constant, tendency for bactericidal action 
against each type to be correlated with the presence or absence of this 
action against all other types.  Further investigation has shown that 
this correlation is  quantitative;  that  is,  killing of large numbers of 
organisms of one type tends to be associated with similar degrees of 
killing for other types.  No greater correlation was, however, found 
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FIG. 2. Percentage o5 persons whose blood kills different numbers of pneumo- 
cocci of various types.  The Roman numerals represent the types of pneumococci. 
to exist between Types II and V or between Types III and VIII than 
was observed for unrelated pairs of strains. 
iWith  the VI a and VI b strains, however, the relation was found to 
be closer.  Their agglutination reactions with immune horse serum, 
as mentioned above, were practically identical.  Both of these strains 
were used in the bloods of 32 persons, which were able to kill 100 or MAXWELL  FINLAND  AND  W.  D.  SUTLIFF  103 
more of each of these organisms.  In  26,  or 81  per  cent,  of  these 
individuals the pneumococcidal titer of the blood for these 2  types 
was the same or showed a  difference of only 10-fold, and in the re- 
maining instances the difference was  100-fold in favor of one strain 
or the other.  Such quantitative differences were interpreted as well 
within the limits of the method and only the results obtained with the 
Type VI b strain were used above, the bloods of all of the subjects 
having been tested with this organism. 
TABLE  III 
Incidence of Mouse Protection by Age and Type 
II 
III 
V 
VI b 
VIII 
All types*... 
1-9 yrs.  15-38 yrs.  40-60 yrs.  Over 64 yrs.  All ages 
z____ _  2  ~  2 
5  0  0  23  521.7  11 
2  0  0  16  318.81  10 
5  0  0  26  415.4  12 
4  1  25.13  22  940.9  13 
2  0  0  23  730.4  13 
i 
.. 
0  0  8  1  12.5  47  6  12.8 
330.C  8  2  25.13  36  8  22.2 
1  8.3  8  0  0  51  5  9.8 
861.5  8  2  25.13  47  20  42.(S 
1  7.7  8  0  0  46  8  17.4 
18  1  5.6  110  2825.5  59  1322.0  40  5  12.5  227  47  20.7 
* The numbers refer to tests and not subjects, as above. 
Results of Mouse Protection  Tests 
A  total of 227 protection tests against the Types II, III, V, VI b 
and VIII pneumococci were performed with the sera of 53 persons all 
of whom were included in the studies for pneumococcidal properties, 
as  reported above.  All 5  types were tested against  the sera of 30 
individuals, and 4,  3 and 2 types used with the sera of 10,  11 and 2 
subjects respectively.  Sera of infants under 1 year of age were not 
studied.  The numbers of persons whose sera protected mice against 
100 or more lethal doses of the various types of pneumococci are shown, 
by age groups, in Table III. 
From this table it appears that mouse protection against the types 104  IMMUNITY  REACTIONS  TO  PNEUMOCOCCI 
of pneumococci studied is  rare in the sera of children, is relatively 
frequent in adult life and is somewhat less frequent in old age.  The 
order of frequency with which protection was found against different 
types of pneumococci is not quite the same as in the case of pneumococ- 
cidal  action.  Type VI  protection was  demonstrated in the sera of 
43 per cent of subjects, Type III protection in 22 per cent and Types 
VIII, II and V in 17,  13 and 10 per cent, respectively.  Except for 
the Type III organism, the order of types is, therefore, analogous to 
that for blood pneumococcidal power. 
A  comparison of  the protective power of  the  same  sera  for  the 
various combinations of pairs of organisms shows similar relationships 
between pairs  of strains  immunologically related and  pairs  not  so 
related.  Thus, of 47 sera tested for both Types II and V, 39 lacked 
protection against both,  2 had protection against both, 4 protected 
against Type II and not against Type V and the remaining 2 protected 
against Type V and not against Type II.  With both Types III and 
VIII  the  sera  of  35  subjects  were  tested.  Of  these,  21  protected 
against neither strain, 1 protected against both, 7 against the former 
only and  6  only against  the latter.  Similar results were obtained 
with the same types in unrelated combinations.  There was,  there- 
fore, no discernible tendency for these sera to show any greater cor- 
relation in their protection against strains considered to be immuno- 
logically related than against those not so related. 
Result of Tests for Agglutinins 
All 8  strains of pneumococci used for pneumococcidal tests were 
also  used to test for agglutinins in the sera of 22  of the young and 
middle aged adults.  None of the sera showed any agglutinins for the 
Types I, II, III, V and IX strains.  With Type VIII, agglutination 
was observed only in equal amounts of serum and antigen in 3 in- 
stances.  The VIa and VI b antigens showed granular agglutination 
in most of the undiluted sera.  Definite agglutination was obtained 
with the VI a  organisms in 3 sera (in 1:1,  1:2  and 1:4 dilutions of 
serum, respectively), but none was obtained with the same sera and 
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Correlations between the Tests 
The  correlation  between  the  3  tests  employed was  found  to  be 
about the same for all of the types used as has  previously been  de- 
scribed  with  respect  to  Types  I,  II  and  III  (1).  Protection  or 
agglutination  in  any given  serum  was,  in  general,  associated  with 
homologous  type  pneumococcidal action  in  the  corresponding  de- 
fibrinated blood.  In  3  sera,  however, protection against  Type III 
pneumococci was demonstrated (100  lethal doses in 2 instances and 
1000 in the 3rd) when the corresponding whole blood failed to kill the 
homologous type organisms. 
Of the 6 instances where agglutinins were found, 3 were associated 
with mouse protection against the homologous organism and 3  had 
no such protection.  All had homologous pneumococcidal power. 
DISCUSSION 
Surprisingly little of specific significance can be obtained from the 
literature with respect to the natural immunity of man to the strains 
of pneumococci previously included in  Group IV.  According to the 
work of Cooper and her associates (2) and other investigators (3-5) we 
must consider these new types as fixed, their specificity being similar, 
immunologically, to  that  of Types I,  II  and  III.  It  may thus be 
expected that  the accuracy of deductions from previous work with 
unclassified Group IV strains would depend largely on whether these 
deductions were based on characteristics of the species rather than on 
type specificity. 
It would be a  tremendous task to carry out any large series of ob- 
servations similar  to  those presented above and utilizing all  of the 
32  type strains identified and classified to date.  The present study 
was, therefore, limited to a  few types, strains of which had been iso- 
lated  relatively frequently in  this  laboratory from human  cases of 
pneumonia.  The Type IX strain was included in this study because 
of  its  peculiar  agglutinating  and  cultural  characteristics which  re- 
mained the same  throughout the  course of this  study.  It  was  as- 
sumed that the remaining strains were representative of their specific 
types  since they were  selected originally  for  their  high  and  stable 
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Robertson and Cornwell (9), however, using recently isolated human 
strains of pathogenic pneumococci found that the reactions of a serum- 
leukocyte mixture  against  different  strains  within  the  type  often 
varied considerably, but  this difference was less, on the whole, than 
that  between types.  The results reported above in  regard to  rela- 
tive virulence should not be applied in a  literal mathematical sense 
to all strains of each type, as additional differences may exist between 
strains of the same type. 
The  comparative  delicacy of  the  pneumococcidal  test  has  been 
referred to here and elsewhere (1).  It has previously been shown that 
the mouse protection test is a more delicate index of the presence of 
type-specific pneumococcic  antibody, in patients recovering from lobar 
pneumonia,  than is  the agglutination  test  (10).  In normal human 
subjects mouse protection against many of the virulent strains has 
been shown to be comparatively infrequent.  Pneumococcidal power, 
however, is far more frequent for every type.  It appears  from the 
present observations that protection is comparatively rare in the first 
decade of life, although pneumococcidal power at this age is almost as 
frequent, for most types, as in early adult life.  This discrepancy may 
depend on the comparative delicacy of these two tests and may thus 
indicate a greater degree of natural immunity in the latter period. 
From the present observations certain deductions may be ventured 
in regard to the immunological reactions of normal human subjects to 
the newly classified types of pneumococci.  These types have been 
shown to differ both in the frequency with which they are killed in 
different human bloods and in the number of organisms so killed.  In 
general, the types most frequently susceptible to the action of human 
blood are also killed in the greatest numbers, the types aligning them- 
selves in  a  definite sequence in  this  respect.  Some types,  such as 
Type VI or Type IX,  are almost universally killed, usually in large 
numbers; others,  like  Type V,  are killed less  frequently.  The age 
frequency curve for pneumococcidal power is probably similar for all 
types,  showing a  peak  in  adult life.  Individual bloods  apparently 
kill different types more or less independently. 
Can these findings be interpreted in terms of the virulence of these 
pneumococcus types for man or in terms of the susceptibility of human 
subjects to the various types?  These questions cannot be answered MAXWELL  FINLAND  AND  W.  D.  SUTLL~F  107 
separately, since virulence and resistance may be determined only in 
relation to each other.  Robertson and Sia (11), however, in working 
with sera of different animals mixed with  standard  suspensions of 
rabbit's leukocytes, found differences in the growth inhibitory action 
of these mixtures, which paralleled the known susceptibility of the 
different  animal species to experimental  pneumococcic  infections.  In a 
similar manner, the frequency of pneumococcidal action in  human 
blood may be considered, indirectly, as an index of the relative viru- 
lence of the different strains for man. 
Two pairs of immunologically related strains, Types II and V and 
Types III and VIII, were here shown not to be related in their reac- 
tions with human blood or serum.  From the present data, no greater 
correlation was observed in human subjects between these pairs of 
strains and other pairs not related by their reactions with artificially 
prepared immune sera.  This lack of obvious correlation was found 
to hold both for pneumococcidal and mouse protection tests.  Similar 
results may be deduced from the small number of earlier observations 
with normal human subjects against atypical Type II strains (prob- 
ably Type V) in mouse protection tests done by Clough (12) and in 
the pneumococcidal tests carried out by Robertson and Cornwell (9). 
The  correlation between the  pneumococcidal action  against  Types 
VIa and VI b, however, indicates a closer relationship between these 
strains and thus tends to support the belief of  Cooper (2) that they 
really belong to the same type. 
It was inferred from previous work with Types I, II and III  (1) 
that the frequency with which killing power was present or absent 
for any combination of types was a matter of chance depending only 
upon  the  frequency with which killing power was present for each 
type.  A closer study of the previous data, as well as those presented 
here, has shown that, in every instance, killing power for both of any 
pair of types was either present or absent in a slightly larger per cent 
of subjects than was expected from calculations made on the basis 
of the per cent of subjects killing  each type separately.  The dis- 
crepancy was often slight, as low as 3 per cent for some combinations; 
but, in others it was 13 per cent higher than the calculated expectancy. 
No greater correlation, however, was observed with types related in 
their agglutination with immune sera and those not so related. 108  IMMUNITY  REACTIONS  TO PNEU~OCOCCI 
The constancy with which this correlation was observed in pneumo- 
coccidal tests with all the types suggests that it may have some sig- 
nificance.  Its interpretation may depend, among other things, upon 
one or both of two factors.  First, it is possible that any contact with a 
given  type pneumococcus which  is  capable  of  stimulating  specific 
immunity carries with it, in addition, a small degree of species immu- 
nity detectable, in some instances, and with some specific type strains, 
by a  sensitive  test  for immunity, such as  the pneumococcidal test. 
Such a  spread of immunity would not be expected to manifest itself 
in specific mouse protection which is a  far less delicate immune re- 
action.  The second factor which may be responsible for this constant 
correlation goes back  still  further in  its  epidemiological source.  It 
is  possible  that,  in  any group  of individuals,  the  conditions which 
bring about immunizing contact with any one type of pneumococcus 
carry with them an increase of probability that  contact with other 
pneumococci will also  occur.  The latter  concept is,  of course,  ap- 
plicable to organisms and viruses widely divergent in their occurrence 
and pathogenicity, but no accurate confirming data are available. 
SUMMARY 
1.  A  group of 72 human subjects were studied with respect to the 
immune reactions  of  their  blood  and  sera  to  Types  I,  II  and  III 
pneumococci and to  4  other types  (V, VI, VIII and  IX)  previously 
included in Group IV. 
2.  The  same general relationships  were observed for all  of these 
types as were previously demonstrated for Types I, II and III.  Each 
type  was  specific  in  relation  to  the  bactericidal  action  of  normal 
human blood and the protective action of normal human serum. 
3.  The frequency with which pneumococcidal action for any pair 
of types was present for both or absent for both in the same blood 
samples was  slightly greater than that calculated from the frequen- 
cies with which each of the types was killed separately. 
4.  No closer correlation could be demonstrated between the reac- 
tion  of the blood of these subjects  to  Types II  and  V  or  between 
Types III and VIII pneumococci, types related in their reaction with 
artificially prepared  immune sera,  than  was  observed between un- 
related strains. MAXWELL FINLAND AND  W.  D.  SUTLIFF  109 
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